Selected research
Industry Research
Topical Steroids Industry Research Report 2026
Market perspective
The global Topical Steroids market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Topical Steroids is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Topical Steroids is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Topical Steroids is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Topical Steroids include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Topical Steroids market in revenue (US$ million) and, where applicable, sales volume (k tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/k tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Topical Steroids.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Topical Steroids Market by Company
Abbott
Sanofi
Novartis
Merck
Roche
Eli Lilly
Pfizer
Glaxosmithkline
Bayer
Taro Pharmaceuticals U.S.A.
Taro Pharmaceuticals
Pure Tek
Nu Care Pharmaceuticals
Galderma
Arbor Pharmaceuticals
Aqua Pharmaceuticals
Apotex
Topical Steroids Segment by Type
Class III
Class II
Class IV
Class I
Class VII
Class VI
Class V
Topical Steroids Segment by Application
Treatment of Dermatitis
Treatment of Rash
Treatment of Eczema
Topical Steroids Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Topical Steroids market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Topical Steroids and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Topical Steroids.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Topical Steroids manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Topical Steroids by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Topical Steroids in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Class III
- Class II
- Class IV
- Class I
- Class VII
- Class VI
- Class V
Applications
- Treatment of Dermatitis
- Treatment of Rash
- Treatment of Eczema
Companies covered
- Abbott
- Sanofi
- Novartis
- Merck
- Roche
- Eli Lilly
- Pfizer
- Glaxosmithkline
- Bayer
- Taro Pharmaceuticals U.S.A.
- Taro Pharmaceuticals
- Pure Tek
- Nu Care Pharmaceuticals
- Galderma
- Arbor Pharmaceuticals
- Aqua Pharmaceuticals
- Apotex
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Topical Steroids by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Class III
- 2.2.3 Class II
- 2.2.4 Class IV
- 2.2.5 Class I
- 2.2.6 Class VII
- 2.2.7 Class VI
- 2.2.8 Class V
- 2.3 Topical Steroids by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Treatment of Dermatitis
- 2.3.3 Treatment of Rash
- 2.3.4 Treatment of Eczema
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Topical Steroids Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Topical Steroids Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Topical Steroids Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Topical Steroids Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Topical Steroids Production by Manufacturers (2021-2026)
- 3.2 Global Topical Steroids Production Value by Manufacturers (2021-2026)
- 3.3 Global Topical Steroids Average Price by Manufacturers (2021-2026)
- 3.4 Global Topical Steroids Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Topical Steroids Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Topical Steroids Manufacturers, Product Type & Application
- 3.7 Global Topical Steroids Manufacturers Established Date
- 3.8 Global Topical Steroids Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Abbott
- 4.1.1 Abbott Topical Steroids Company Information
- 4.1.2 Abbott Topical Steroids Business Overview
- 4.1.3 Abbott Topical Steroids Production, Value and Gross Margin (2021-2026)
- 4.1.4 Abbott Product Portfolio
- 4.1.5 Abbott Recent Developments
- 4.2 Sanofi
- 4.2.1 Sanofi Topical Steroids Company Information
- 4.2.2 Sanofi Topical Steroids Business Overview
- 4.2.3 Sanofi Topical Steroids Production, Value and Gross Margin (2021-2026)
- 4.2.4 Sanofi Product Portfolio
- 4.2.5 Sanofi Recent Developments
- 4.3 Novartis
- 4.3.1 Novartis Topical Steroids Company Information
- 4.3.2 Novartis Topical Steroids Business Overview
- 4.3.3 Novartis Topical Steroids Production, Value and Gross Margin (2021-2026)
- 4.3.4 Novartis Product Portfolio
- 4.3.5 Novartis Recent Developments
- 4.4 Merck
- 4.4.1 Merck Topical Steroids Company Information
- 4.4.2 Merck Topical Steroids Business Overview
- 4.4.3 Merck Topical Steroids Production, Value and Gross Margin (2021-2026)
- 4.4.4 Merck Product Portfolio
- 4.4.5 Merck Recent Developments
- 4.5 Roche
- 4.5.1 Roche Topical Steroids Company Information
- 4.5.2 Roche Topical Steroids Business Overview
- 4.5.3 Roche Topical Steroids Production, Value and Gross Margin (2021-2026)
- 4.5.4 Roche Product Portfolio
- 4.5.5 Roche Recent Developments
- 4.6 Eli Lilly
- 4.6.1 Eli Lilly Topical Steroids Company Information
- 4.6.2 Eli Lilly Topical Steroids Business Overview
- 4.6.3 Eli Lilly Topical Steroids Production, Value and Gross Margin (2021-2026)
- 4.6.4 Eli Lilly Product Portfolio
- 4.6.5 Eli Lilly Recent Developments
- 4.7 Pfizer
- 4.7.1 Pfizer Topical Steroids Company Information
- 4.7.2 Pfizer Topical Steroids Business Overview
- 4.7.3 Pfizer Topical Steroids Production, Value and Gross Margin (2021-2026)
- 4.7.4 Pfizer Product Portfolio
- 4.7.5 Pfizer Recent Developments
- 4.8 Glaxosmithkline
- 4.8.1 Glaxosmithkline Topical Steroids Company Information
- 4.8.2 Glaxosmithkline Topical Steroids Business Overview
- 4.8.3 Glaxosmithkline Topical Steroids Production, Value and Gross Margin (2021-2026)
- 4.8.4 Glaxosmithkline Product Portfolio
- 4.8.5 Glaxosmithkline Recent Developments
- 4.9 Bayer
- 4.9.1 Bayer Topical Steroids Company Information
- 4.9.2 Bayer Topical Steroids Business Overview
- 4.9.3 Bayer Topical Steroids Production, Value and Gross Margin (2021-2026)
- 4.9.4 Bayer Product Portfolio
- 4.9.5 Bayer Recent Developments
- 4.10 Taro Pharmaceuticals U.S.A.
- 4.10.1 Taro Pharmaceuticals U.S.A. Topical Steroids Company Information
- 4.10.2 Taro Pharmaceuticals U.S.A. Topical Steroids Business Overview
- 4.10.3 Taro Pharmaceuticals U.S.A. Topical Steroids Production, Value and Gross Margin (2021-2026)
- 4.10.4 Taro Pharmaceuticals U.S.A. Product Portfolio
- 4.10.5 Taro Pharmaceuticals U.S.A. Recent Developments
- 4.11 Taro Pharmaceuticals
- 4.11.1 Taro Pharmaceuticals Topical Steroids Company Information
- 4.11.2 Taro Pharmaceuticals Topical Steroids Business Overview
- 4.11.3 Taro Pharmaceuticals Topical Steroids Production, Value and Gross Margin (2021-2026)
- 4.11.4 Taro Pharmaceuticals Product Portfolio
- 4.11.5 Taro Pharmaceuticals Recent Developments
- 4.12 Pure Tek
- 4.12.1 Pure Tek Topical Steroids Company Information
- 4.12.2 Pure Tek Topical Steroids Business Overview
- 4.12.3 Pure Tek Topical Steroids Production, Value and Gross Margin (2021-2026)
- 4.12.4 Pure Tek Product Portfolio
- 4.12.5 Pure Tek Recent Developments
- 4.13 Nu Care Pharmaceuticals
- 4.13.1 Nu Care Pharmaceuticals Topical Steroids Company Information
- 4.13.2 Nu Care Pharmaceuticals Topical Steroids Business Overview
- 4.13.3 Nu Care Pharmaceuticals Topical Steroids Production, Value and Gross Margin (2021-2026)
- 4.13.4 Nu Care Pharmaceuticals Product Portfolio
- 4.13.5 Nu Care Pharmaceuticals Recent Developments
- 4.14 Galderma
- 4.14.1 Galderma Topical Steroids Company Information
- 4.14.2 Galderma Topical Steroids Business Overview
- 4.14.3 Galderma Topical Steroids Production, Value and Gross Margin (2021-2026)
- 4.14.4 Galderma Product Portfolio
- 4.14.5 Galderma Recent Developments
- 4.15 Arbor Pharmaceuticals
- 4.15.1 Arbor Pharmaceuticals Topical Steroids Company Information
- 4.15.2 Arbor Pharmaceuticals Topical Steroids Business Overview
- 4.15.3 Arbor Pharmaceuticals Topical Steroids Production, Value and Gross Margin (2021-2026)
- 4.15.4 Arbor Pharmaceuticals Product Portfolio
- 4.15.5 Arbor Pharmaceuticals Recent Developments
- 4.16 Aqua Pharmaceuticals
- 4.16.1 Aqua Pharmaceuticals Topical Steroids Company Information
- 4.16.2 Aqua Pharmaceuticals Topical Steroids Business Overview
- 4.16.3 Aqua Pharmaceuticals Topical Steroids Production, Value and Gross Margin (2021-2026)
- 4.16.4 Aqua Pharmaceuticals Product Portfolio
- 4.16.5 Aqua Pharmaceuticals Recent Developments
- 4.17 Apotex
- 4.17.1 Apotex Topical Steroids Company Information
- 4.17.2 Apotex Topical Steroids Business Overview
- 4.17.3 Apotex Topical Steroids Production, Value and Gross Margin (2021-2026)
- 4.17.4 Apotex Product Portfolio
- 4.17.5 Apotex Recent Developments
5 Global Topical Steroids Production by Region
- 5.1 Global Topical Steroids Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Topical Steroids Production by Region: 2021-2032
- 5.2.1 Global Topical Steroids Production by Region: 2021-2026
- 5.2.2 Global Topical Steroids Production Forecast by Region (2027-2032)
- 5.3 Global Topical Steroids Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Topical Steroids Production Value by Region: 2021-2032
- 5.4.1 Global Topical Steroids Production Value by Region: 2021-2026
- 5.4.2 Global Topical Steroids Production Value Forecast by Region (2027-2032)
- 5.5 Global Topical Steroids Market Price Analysis by Region (2021-2026)
- 5.6 Global Topical Steroids Production and Value, YOY Growth
- 5.6.1 North America Topical Steroids Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Topical Steroids Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Topical Steroids Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Topical Steroids Production Value Estimates and Forecasts (2021-2032)
6 Global Topical Steroids Consumption by Region
- 6.1 Global Topical Steroids Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Topical Steroids Consumption by Region (2021-2032)
- 6.2.1 Global Topical Steroids Consumption by Region: 2021-2026
- 6.2.2 Global Topical Steroids Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Topical Steroids Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Topical Steroids Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Topical Steroids Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Topical Steroids Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Topical Steroids Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Topical Steroids Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Topical Steroids Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Topical Steroids Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Topical Steroids Production by Type (2021-2032)
- 7.1.1 Global Topical Steroids Production by Type (2021-2032) & (k tons)
- 7.1.2 Global Topical Steroids Production Market Share by Type (2021-2032)
- 7.2 Global Topical Steroids Production Value by Type (2021-2032)
- 7.2.1 Global Topical Steroids Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Topical Steroids Production Value Market Share by Type (2021-2032)
- 7.3 Global Topical Steroids Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Topical Steroids Production by Application (2021-2032)
- 8.1.1 Global Topical Steroids Production by Application (2021-2032) & (k tons)
- 8.1.2 Global Topical Steroids Production Market Share by Application (2021-2032)
- 8.2 Global Topical Steroids Production Value by Application (2021-2032)
- 8.2.1 Global Topical Steroids Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Topical Steroids Production Value Market Share by Application (2021-2032)
- 8.3 Global Topical Steroids Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Topical Steroids Value Chain Analysis
- 9.1.1 Topical Steroids Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Topical Steroids Production Mode & Process
- 9.2 Topical Steroids Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Topical Steroids Distributors
- 9.2.3 Topical Steroids Customers
10 Global Topical Steroids Analyzing Market Dynamics
- 10.1 Topical Steroids Industry Trends
- 10.2 Topical Steroids Industry Drivers
- 10.3 Topical Steroids Industry Opportunities and Challenges
- 10.4 Topical Steroids Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst